ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-10S6235
Home | Market Reports | Health| Nursing
Global Autologous Matrix Induced Chondrogenesis AMIC Market Insights Forecast to 2028
BUY CHAPTERS

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Research Report 2024

Code: QYRE-Auto-10S6235
Report
August 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Anika Therapeutics; Inc.
Arthro Kinetics
B Braun Melsungen AG
BioTissue
Cartiheal
Geistlich Pharma Ag
JRI Orthopaedics Ltd
Matricel
Smith & Nephew plc
Zimmer Biomet Holdings

Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size

The global Autologous Matrix-Induced Chondrogenesis (AMIC) market was valued at US$ 101.7 million in 2023 and is anticipated to reach US$ 142.5 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Autologous Matrix-Induced Chondrogenesis (AMIC) Market

Autologous Matrix-Induced Chondrogenesis (AMIC) Market

North American market for Autologous Matrix-Induced Chondrogenesis (AMIC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autologous Matrix-Induced Chondrogenesis (AMIC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Autologous Matrix-Induced Chondrogenesis (AMIC) in Knee Cartilage Repair is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Autologous Matrix-Induced Chondrogenesis (AMIC) include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH and Smith & Nephew plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autologous Matrix-Induced Chondrogenesis (AMIC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Matrix-Induced Chondrogenesis (AMIC).

Report Scope

The Autologous Matrix-Induced Chondrogenesis (AMIC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autologous Matrix-Induced Chondrogenesis (AMIC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Matrix-Induced Chondrogenesis (AMIC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Autologous Matrix-Induced Chondrogenesis (AMIC) Market Report

Report Metric Details
Report Name Autologous Matrix-Induced Chondrogenesis (AMIC) Market
Accounted market size in 2023 US$ 101.7 million
Forecasted market size in 2030 US$ 142.5 million
CAGR 4.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc, Zimmer Biomet Holdings
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Autologous Matrix-Induced Chondrogenesis (AMIC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Autologous Matrix-Induced Chondrogenesis (AMIC) Market growing?

Ans: The Autologous Matrix-Induced Chondrogenesis (AMIC) Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Autologous Matrix-Induced Chondrogenesis (AMIC) Market size in 2030?

Ans: The Autologous Matrix-Induced Chondrogenesis (AMIC) Market size in 2030 will be US$ 142.5 million.

Who are the main players in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market report?

Ans: The main players in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market are Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc, Zimmer Biomet Holdings

What are the Application segmentation covered in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market report?

Ans: The Applications covered in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market report are Knee Cartilage Repair, Hip Cartilage Repair, Elbow Cartilage Repair, Others

What are the Type segmentation covered in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market report?

Ans: The Types covered in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market report are Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), Polylactic-Co-Glycolic Acid (PGLA), Others

Recommended Reports

Orthopedic Implants

Regenerative Medicine

Musculoskeletal Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hyaluronic Acid
1.2.3 Collagen
1.2.4 Polyethylene Glycol (PEG)
1.2.5 Polylactic-Co-Glycolic Acid (PGLA)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Knee Cartilage Repair
1.3.3 Hip Cartilage Repair
1.3.4 Elbow Cartilage Repair
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Perspective (2019-2030)
2.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Growth Trends by Region
2.2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Size by Region (2019-2024)
2.2.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Region (2025-2030)
2.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Dynamics
2.3.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Industry Trends
2.3.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Drivers
2.3.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Challenges
2.3.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Revenue
3.1.1 Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Revenue (2019-2024)
3.1.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Players (2019-2024)
3.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue
3.4 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Concentration Ratio
3.4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in 2023
3.5 Autologous Matrix-Induced Chondrogenesis (AMIC) Key Players Head office and Area Served
3.6 Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Product Solution and Service
3.7 Date of Enter into Autologous Matrix-Induced Chondrogenesis (AMIC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Matrix-Induced Chondrogenesis (AMIC) Breakdown Data by Type
4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Size by Type (2019-2024)
4.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Type (2025-2030)
5 Autologous Matrix-Induced Chondrogenesis (AMIC) Breakdown Data by Application
5.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Historic Market Size by Application (2019-2024)
5.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2019-2030)
6.2 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024)
6.4 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2019-2030)
7.2 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024)
7.4 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2019-2030)
8.2 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (2019-2024)
8.4 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2019-2030)
9.2 Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024)
9.4 Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2019-2030)
10.2 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024)
10.4 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anika Therapeutics, Inc.
11.1.1 Anika Therapeutics, Inc. Company Detail
11.1.2 Anika Therapeutics, Inc. Business Overview
11.1.3 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.1.4 Anika Therapeutics, Inc. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.1.5 Anika Therapeutics, Inc. Recent Development
11.2 Arthro-Kinetics
11.2.1 Arthro-Kinetics Company Detail
11.2.2 Arthro-Kinetics Business Overview
11.2.3 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.2.4 Arthro-Kinetics Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.2.5 Arthro-Kinetics Recent Development
11.3 B. Braun Melsungen AG
11.3.1 B. Braun Melsungen AG Company Detail
11.3.2 B. Braun Melsungen AG Business Overview
11.3.3 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.3.4 B. Braun Melsungen AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.3.5 B. Braun Melsungen AG Recent Development
11.4 BioTissue AG
11.4.1 BioTissue AG Company Detail
11.4.2 BioTissue AG Business Overview
11.4.3 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.4.4 BioTissue AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.4.5 BioTissue AG Recent Development
11.5 CartiHeal
11.5.1 CartiHeal Company Detail
11.5.2 CartiHeal Business Overview
11.5.3 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.5.4 CartiHeal Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.5.5 CartiHeal Recent Development
11.6 Geistlich Pharma AG
11.6.1 Geistlich Pharma AG Company Detail
11.6.2 Geistlich Pharma AG Business Overview
11.6.3 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.6.4 Geistlich Pharma AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.6.5 Geistlich Pharma AG Recent Development
11.7 JRI Orthopaedics Ltd.
11.7.1 JRI Orthopaedics Ltd. Company Detail
11.7.2 JRI Orthopaedics Ltd. Business Overview
11.7.3 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.7.4 JRI Orthopaedics Ltd. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.7.5 JRI Orthopaedics Ltd. Recent Development
11.8 Matricel GmbH
11.8.1 Matricel GmbH Company Detail
11.8.2 Matricel GmbH Business Overview
11.8.3 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.8.4 Matricel GmbH Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.8.5 Matricel GmbH Recent Development
11.9 Smith & Nephew plc
11.9.1 Smith & Nephew plc Company Detail
11.9.2 Smith & Nephew plc Business Overview
11.9.3 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.9.4 Smith & Nephew plc Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.9.5 Smith & Nephew plc Recent Development
11.10 Zimmer Biomet Holdings
11.10.1 Zimmer Biomet Holdings Company Detail
11.10.2 Zimmer Biomet Holdings Business Overview
11.10.3 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Introduction
11.10.4 Zimmer Biomet Holdings Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
11.10.5 Zimmer Biomet Holdings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Anika Therapeutics; Inc.
Arthro Kinetics
B Braun Melsungen AG
BioTissue
Cartiheal
Geistlich Pharma Ag
JRI Orthopaedics Ltd
Matricel
Smith & Nephew plc
Zimmer Biomet Holdings
List of Tables
    Table 1. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Hyaluronic Acid
    Table 3. Key Players of Collagen
    Table 4. Key Players of Polyethylene Glycol (PEG)
    Table 5. Key Players of Polylactic-Co-Glycolic Acid (PGLA)
    Table 6. Key Players of Others
    Table 7. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Region (2019-2024)
    Table 11. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Region (2025-2030)
    Table 13. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Trends
    Table 14. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Drivers
    Table 15. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Challenges
    Table 16. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Restraints
    Table 17. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Players (2019-2024)
    Table 19. Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) as of 2023)
    Table 20. Ranking of Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Autologous Matrix-Induced Chondrogenesis (AMIC) Product Solution and Service
    Table 24. Date of Enter into Autologous Matrix-Induced Chondrogenesis (AMIC) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Type (2019-2024)
    Table 28. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Type (2025-2030)
    Table 30. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Application (2019-2024)
    Table 32. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Application (2025-2030)
    Table 34. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Anika Therapeutics, Inc. Company Detail
    Table 50. Anika Therapeutics, Inc. Business Overview
    Table 51. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 52. Anika Therapeutics, Inc. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 53. Anika Therapeutics, Inc. Recent Development
    Table 54. Arthro-Kinetics Company Detail
    Table 55. Arthro-Kinetics Business Overview
    Table 56. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 57. Arthro-Kinetics Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 58. Arthro-Kinetics Recent Development
    Table 59. B. Braun Melsungen AG Company Detail
    Table 60. B. Braun Melsungen AG Business Overview
    Table 61. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 62. B. Braun Melsungen AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 63. B. Braun Melsungen AG Recent Development
    Table 64. BioTissue AG Company Detail
    Table 65. BioTissue AG Business Overview
    Table 66. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 67. BioTissue AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 68. BioTissue AG Recent Development
    Table 69. CartiHeal Company Detail
    Table 70. CartiHeal Business Overview
    Table 71. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 72. CartiHeal Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 73. CartiHeal Recent Development
    Table 74. Geistlich Pharma AG Company Detail
    Table 75. Geistlich Pharma AG Business Overview
    Table 76. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 77. Geistlich Pharma AG Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 78. Geistlich Pharma AG Recent Development
    Table 79. JRI Orthopaedics Ltd. Company Detail
    Table 80. JRI Orthopaedics Ltd. Business Overview
    Table 81. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 82. JRI Orthopaedics Ltd. Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 83. JRI Orthopaedics Ltd. Recent Development
    Table 84. Matricel GmbH Company Detail
    Table 85. Matricel GmbH Business Overview
    Table 86. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 87. Matricel GmbH Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 88. Matricel GmbH Recent Development
    Table 89. Smith & Nephew plc Company Detail
    Table 90. Smith & Nephew plc Business Overview
    Table 91. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 92. Smith & Nephew plc Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 93. Smith & Nephew plc Recent Development
    Table 94. Zimmer Biomet Holdings Company Detail
    Table 95. Zimmer Biomet Holdings Business Overview
    Table 96. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Product
    Table 97. Zimmer Biomet Holdings Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024) & (US$ Million)
    Table 98. Zimmer Biomet Holdings Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type: 2023 VS 2030
    Figure 3. Hyaluronic Acid Features
    Figure 4. Collagen Features
    Figure 5. Polyethylene Glycol (PEG) Features
    Figure 6. Polylactic-Co-Glycolic Acid (PGLA) Features
    Figure 7. Others Features
    Figure 8. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application: 2023 VS 2030
    Figure 10. Knee Cartilage Repair Case Studies
    Figure 11. Hip Cartilage Repair Case Studies
    Figure 12. Elbow Cartilage Repair Case Studies
    Figure 13. Others Case Studies
    Figure 14. Autologous Matrix-Induced Chondrogenesis (AMIC) Report Years Considered
    Figure 15. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Region: 2023 VS 2030
    Figure 18. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Players in 2023
    Figure 19. Global Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Matrix-Induced Chondrogenesis (AMIC) as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in 2023
    Figure 21. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Country (2019-2030)
    Figure 23. United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Country (2019-2030)
    Figure 27. Germany Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Region (2019-2030)
    Figure 35. China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Country (2019-2030)
    Figure 43. Mexico Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Country (2019-2030)
    Figure 47. Turkey Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Anika Therapeutics, Inc. Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 50. Arthro-Kinetics Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 51. B. Braun Melsungen AG Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 52. BioTissue AG Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 53. CartiHeal Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 54. Geistlich Pharma AG Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 55. JRI Orthopaedics Ltd. Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 56. Matricel GmbH Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 57. Smith & Nephew plc Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 58. Zimmer Biomet Holdings Revenue Growth Rate in Autologous Matrix-Induced Chondrogenesis (AMIC) Business (2019-2024)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Autologous Matrixinduced Chondrogenesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cartilage Regenerative Device Market Research Report 2025
Global Knee Cartilage Regeneration Treatment Market Research Report 2024
Global Artificial Dermal Matrix Market Research Report 2025
Cartilage Repair Cartilage Regeneration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autologous Fat Grafting Device Market Research Report 2025
Global Reconstructive Tissue Matrix Market Research Report 2025
Orthopedic Tissue Matrix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meshed Acellular Dermal Matrix Market Research Report 2024
Global Cell Based Artificial Meat Market Research Report 2025
Global Chondroprotective Agent Market Research Report 2025
Global Cartilage Allograft Market Research Report 2024
Global Autologous Stem Cell Based Therapies Market Research Report 2024
Tissue Engineered Collagen Biomaterials Market
Global Vascular Tissue Matrix Market Research Report 2024
Autologous Matrix induced Chondrogenesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Breast Augmentation Material Market Research Report 2025
Global Extracellular Matrix Patch Market Research Report 2025
Global Articular Cartilage Repair Scaffold Market Research Report 2024
Global Intraosseous Implant Market Research Report 2024

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions